Validation of an In-House-Developed GC-MS Method for 5α-Cholestanol According to ISO 15189:2012 Requirements.

Coker C., Uysal S.

Laboratory medicine, 2021 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası:
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1093/labmed/lmab095
  • Dergi Adı: Laboratory medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE
  • Anahtar Kelimeler: cholestanol, GC-MS, measurement uncertainty, proficiency testing, clinical laboratory, method performance, CEREBROTENDINOUS XANTHOMATOSIS, QUALITY-CONTROL, DIAGNOSIS, LABORATORIES, CHOLESTANOL, UNCERTAINTY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: The aim of this study was to validate a gas chromatography-mass spectrometry (GC-MS) method for the measurement of 5 alpha-cholestanol in the clinical laboratory in agreement with ISO 15189:2012.